Construction of ammonia death-related lncRNA prognostic signature model and immunomodulatory effect in glioblastoma multiforme
Brain Research · 2026-07 · 1882 · 150266
DOI: 10.1016/j.brainres.2026.150266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026-07. Verfasst von Zhe Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Bethune Hospital of Jilin University, 130000 Changchun, Jilin, China. Hauptthemen laut MEDLINE: Glioblastoma, RNA, Long Noncoding, Brain Neoplasms, Ammonia. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Administration of Traditional Chinese Medicine of Jilin Province.
Abstract (Originalsprache)
BACKGROUND: Glioblastoma (GBM) is characterized by "glutamine addiction," a metabolic state that generates toxic ammonia byproducts. We explored the prognostic value of long non-coding RNAs (lncRNAs) associated with ammonia-induced cell death-a novel mechanism distinct from apoptosis and ferroptosis-to identify potential biomarkers and elucidate the metabolic-immune landscape of GBM. METHODS: Ammonia death-associated genes were identified via co-expression analysis in TCGA-GBM datasets. A prognostic signature was constructed using LASSO-Cox regression and validated in independent CGGA cohorts. Single-cell RNA sequencing (scRNA-seq) was utilized to characterize cellular heterogeneity and map ammonia death scores to specific cell populations. The expression of signature lncRNAs was validated in vitro using human GBM cell lines (U-251, U-87 MG) and normal human astrocytes via RT-qPCR. RESULTS: A robust three-lncRNA signature (LINC00645, AC011451.4, AC093627.22) was established. The high-risk score served as an independent predictor of significantly poorer overall survival (P < 0.001). scRNA-seq revealed that regulatory T cells (Tregs) and macrophages exhibited the highest ammonia death scores. Consistently, high-risk tumors displayed a profoundly immunosuppressive microenvironment, characterized by increased infiltration of M2 macrophages and Tregs, elevated ESTIMATE scores, and upregulation of immune checkpoints (e.g., PD-L1, IDO1). RT-qPCR results confirmed the dysregulated expression of these lncRNAs in GBM cells consistent with bioinformatic predictions. CONCLUSIONS: This novel signature effectively links metabolic ammonia stress to immune evasion in GBM. It serves as a reliable prognostic tool and suggests that targeting the ammonia death-related metabolic-immune axis could offer new avenues for personalizing immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Bethune Hospital of Jilin University, 130000 Changchun, Jilin, China.
- Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University, Jiangmen 529000, China.
- Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University, Jiangmen 529000, China; Jiangmen Xinhui Chenpi Key Laboratory, 529000 Jiangmen, Guangdong, China.
- Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University, Jiangmen 529000, China. Electronic address: iampet@126.com.
- Affiliated Jiangmen Traditional Chinese Medicine Hospital of Jinan University, Jiangmen 529000, China. Electronic address: liujinman77@126.com.
Förderung
- Administration of Traditional Chinese Medicine of Jilin Province
Zitieren
APA
Han, Z., Zhong, C., Tan, E., He, M., & Liu, J. (2026). Construction of ammonia death-related lncRNA prognostic signature model and immunomodulatory effect in glioblastoma multiforme. Brain Research, 1882, 150266. https://doi.org/10.1016/j.brainres.2026.150266
Vancouver
Han Z, Zhong C, Tan E, He M, Liu J. Construction of ammonia death-related lncRNA prognostic signature model and immunomodulatory effect in glioblastoma multiforme. Brain Research. 2026;1882:150266. doi:10.1016/j.brainres.2026.150266
BibTeX
@article{Han2026,
author = {Han, Zhe and Zhong, Cheng and Tan, Eyu and He, Mingliang and Liu, Jinman},
title = {Construction of ammonia death-related lncRNA prognostic signature model and immunomodulatory effect in glioblastoma multiforme},
journal = {Brain Research},
year = {2026},
volume = {1882},
pages = {150266},
doi = {10.1016/j.brainres.2026.150266}
}
EUVIMED